MedPath
NMPA Approval

Theophylline Sustained-release Tablets

国药准字H20033244

April 15, 2024

Drug Information

茶碱缓释片

片剂

0.1g(以C7H8N4O2计)

化学药品

April 15, 2024

Company Information

Applicant Company

广东省中山火炬开发区沿江东二路12号

Manufacturing Company

广东省中山火炬开发区沿江东二路12号

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

茶碱缓释片 - NMPA 批准文号 | MedPath